DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cells

Leukemia

Volumn 10, Issue 6, 1996, Pages 984-990

  Britos Bray, M ^a   Sacchi, N ^b   Friedman, A D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

AML1; Differentiation; Leukemia; Myeloid

Indexed keywords

DNA BINDING PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MUTANT PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CLONE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME 21; CHROMOSOME 3; CHROMOSOME 8; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION;

EID: 0030038668     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kamachi Y, Ogawa E, Asano M, Ishida S, Murakami Y, Satake M, Ito Y, Shigesada K. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol 1990; 64: 4808-4819.
2. Satake M, Inuzuka M, Shigesada K, Oikawa T, Ito Y. Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells. Jpn J Cancer Res 1992; 83: 714-722.
3. Wang S, Speck NA. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol Cell Biol 1992; 12: 89-102.
4. Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M, Ito Y. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 1993; 8: 809-814.
5. Ogawa E, Inuzuka M, Maruyamna M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 1993; 194: 314-331.
6. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci USA 1993; 90: 6859-6863.
7. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 1993; 13: 3324-3339.
8. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y. AML1, AML2, and AML3, the human members of the runt domain gene-family. Genomics 1994; 23: 425-432.
9. Meyers S, Downing JR, Hiebert SW. Identification of AML1 and the (8.21) translocation protein AML1-ETO as sequence specific DNA binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 1993; 13: 6336-6345.
10. Bae SC, Ogawa E, Maruyama M, Oka H, Satak M, Shigesada K, Jenkin KA, Gilbert DJ, Copeland NG, Ito Y. PEBP2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol 1994; 14: 3242-3252.
11. Liu P, Tarle SA, Hajre A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041-1044.
12. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991; 88: 10431-10434.
13. Nisson PE, Watkins PC, Sacchi N. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. Cancer Genet Cytogenet 1992; 63: 81-88.
14. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley JH, Drabkin H. Identification of breakpoints in t(8.211 acute myeloid leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992; 80: 1825-1831.
15. Nucifora G, Begy CR, Erickson P, Drabkin HA, Rowley JD. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER1. Proc Natl Acad Sci USA 1993; 90: 7784-7788.
16. Mitani K, Ogawa S, Miyoshi H, Mano H, Yazaki Y, Ohki M, Hirai H. Generation of the AML1/Evi-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis of chronic myelocytic leukemia. EMBO J 1994; 13: 504-510.
17. Sacchi N, Nisson PE, Watkins PC, Faustinella F, Wijsman J, Hagemeijer A. AML1 fusion transcripts in t(3;21) positive leukemia. Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts. Genes Chromosoms Cancer 1994; 11: 226-236.
18. Mitelman F, Heim S, Quantitative acute leukemia cytogenetics. Genes Chromosoms Cancer 1992; 5: 57-66.
19. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993; 2: 2715-2721.
20. Tighe JE, Calabi F. Alternative, out-of-frame runt/MTG8 transcripts are encoded by the derivative(8) chromosome in the t(8.21) of acute myeloid leukemia M2. Blood 1994; 84: 2115-2121.
21. Greenberger JS, Sakaeeny M, Humphries RK, Eaves CJ, Eckner RJ. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 1983; 80: 2931-2935.
22. Valtieri M, Tweardy DJ, Caracciolo D, Johnson K, Mavilio F, Altman S, Snatoli D, Rovera G. Regulation of proliterative and differentiative responses in a murine progenitor cell line. J Immunol 1987; 138: 3829-3835.
23. Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert S and Friedman AD. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBFβ oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol 1994; 14: 5558-5568.
24. Zhang DE, Ken-Ichiro F, Hetherington CJ, Shapiro LH, Chen HM, Look TA, Tenen DC. Identification of a region which directs the monocytic activity of the CSF-1 (M-CSF) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol 1994; 14: 8085-8095.
25. Warner NL, Moore MAS, Metcalf D. A transplantable myelomonocytic leukemia in Balb/c mice: cytology, karyotype, and murimadase activity. J Natl Cancer Inst 1969; 43: 963-982.
26. Scott LM, Civin CI, Rorth P, Friedman AD. A novel expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 1992; 80: 1725-1735.
27. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988; 85: 6460-6464.
28. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral receptors with multiple durg selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587-3596.
29. Digram JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475-1489.
30. Cameron S, Taylor DS, TePas EC, Speck NA, Mathey-Prevot B. Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting. Blood 1994; 83: 2851-2859.
31. Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y, Hirai H. An acute myeloid leukemia gene, AML1, regulates hematopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J 1995; 14: 341-350.
32. Suzow J, Friedman AD. The murine myeloperoxidase promoter contains several functional elements - one element binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1). Mol Cell Biol 1993; 13: 2141-2151.
33. Sakakura C, Yamaguchi-Iwai Y, Satake M, Bae SC, Takahashi A, Ogawa E, Hagiwara A, Takahashi T, Murakami A, Makino K, Nakagawa N, Kamada N, Ito Y. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proc Natl Acad Sci USA 1994; 91: 11723-11727.
34. Meyers S, Lenny N, Hiebert SW. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol 1995; 15: 1974-1982.